Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.98095204 |
2 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.11759670 |
3 | synaptic vesicle exocytosis (GO:0016079) | 5.09150307 |
4 | * positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.06983228 |
5 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.89925922 |
6 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.88480227 |
7 | vocalization behavior (GO:0071625) | 4.86585973 |
8 | behavioral response to nicotine (GO:0035095) | 4.81636617 |
9 | synaptic vesicle maturation (GO:0016188) | 4.77339216 |
10 | locomotory exploration behavior (GO:0035641) | 4.71672483 |
11 | glutamate secretion (GO:0014047) | 4.68839032 |
12 | protein localization to synapse (GO:0035418) | 4.60342387 |
13 | * regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.55689909 |
14 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.50631856 |
15 | neuron cell-cell adhesion (GO:0007158) | 4.44737151 |
16 | synaptic transmission, glutamatergic (GO:0035249) | 4.31065766 |
17 | regulation of synaptic vesicle transport (GO:1902803) | 4.26955634 |
18 | neuron-neuron synaptic transmission (GO:0007270) | 4.26782855 |
19 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.25312088 |
20 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.19883230 |
21 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.18032740 |
22 | glutamate receptor signaling pathway (GO:0007215) | 4.15138730 |
23 | neuronal action potential propagation (GO:0019227) | 4.13266869 |
24 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.11440866 |
25 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.03243781 |
26 | * neurotransmitter secretion (GO:0007269) | 3.99332302 |
27 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.97870765 |
28 | presynaptic membrane assembly (GO:0097105) | 3.93562841 |
29 | cellular potassium ion homeostasis (GO:0030007) | 3.87002746 |
30 | positive regulation of synapse maturation (GO:0090129) | 3.84504431 |
31 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.81422846 |
32 | retinal cone cell development (GO:0046549) | 3.79305678 |
33 | presynaptic membrane organization (GO:0097090) | 3.76851722 |
34 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.74954691 |
35 | response to pheromone (GO:0019236) | 3.74294527 |
36 | response to histamine (GO:0034776) | 3.69385828 |
37 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.62339946 |
38 | rhodopsin mediated signaling pathway (GO:0016056) | 3.62123308 |
39 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.62037769 |
40 | cerebellar granule cell differentiation (GO:0021707) | 3.61193594 |
41 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.60985688 |
42 | long-term memory (GO:0007616) | 3.57030547 |
43 | synaptic vesicle endocytosis (GO:0048488) | 3.56513110 |
44 | striatum development (GO:0021756) | 3.56438504 |
45 | * regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.55538177 |
46 | * regulation of postsynaptic membrane potential (GO:0060078) | 3.53997115 |
47 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.53788637 |
48 | detection of light stimulus involved in visual perception (GO:0050908) | 3.53788637 |
49 | * membrane hyperpolarization (GO:0060081) | 3.47526931 |
50 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.46893949 |
51 | innervation (GO:0060384) | 3.45726086 |
52 | exploration behavior (GO:0035640) | 3.45179099 |
53 | regulation of neurotransmitter secretion (GO:0046928) | 3.44924091 |
54 | gamma-aminobutyric acid transport (GO:0015812) | 3.44471168 |
55 | long-term synaptic potentiation (GO:0060291) | 3.43497994 |
56 | * neurotransmitter transport (GO:0006836) | 3.43154970 |
57 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.43075179 |
58 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.42905620 |
59 | * positive regulation of membrane potential (GO:0045838) | 3.41892955 |
60 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.41331538 |
61 | prepulse inhibition (GO:0060134) | 3.40926211 |
62 | membrane depolarization during action potential (GO:0086010) | 3.38113023 |
63 | behavioral response to cocaine (GO:0048148) | 3.35655183 |
64 | regulation of synapse structural plasticity (GO:0051823) | 3.35409316 |
65 | neuronal action potential (GO:0019228) | 3.31910750 |
66 | retinal rod cell development (GO:0046548) | 3.31583081 |
67 | positive regulation of neurotransmitter transport (GO:0051590) | 3.31036646 |
68 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.29199163 |
69 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.29168342 |
70 | postsynaptic membrane organization (GO:0001941) | 3.26803655 |
71 | dopamine transport (GO:0015872) | 3.26330493 |
72 | transmission of nerve impulse (GO:0019226) | 3.26062952 |
73 | regulation of neurotransmitter transport (GO:0051588) | 3.25096296 |
74 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.24635106 |
75 | nucleobase catabolic process (GO:0046113) | 3.24218457 |
76 | dendritic spine morphogenesis (GO:0060997) | 3.20588438 |
77 | layer formation in cerebral cortex (GO:0021819) | 3.18498223 |
78 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.18032239 |
79 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.17569033 |
80 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.15398663 |
81 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.14445644 |
82 | neuromuscular synaptic transmission (GO:0007274) | 3.13277768 |
83 | synapse assembly (GO:0007416) | 3.13262737 |
84 | regulation of synaptic plasticity (GO:0048167) | 3.11247564 |
85 | protein polyglutamylation (GO:0018095) | 3.10603174 |
86 | sodium ion export (GO:0071436) | 3.09385249 |
87 | proline transport (GO:0015824) | 3.08669756 |
88 | behavioral defense response (GO:0002209) | 3.07537619 |
89 | behavioral fear response (GO:0001662) | 3.07537619 |
90 | * membrane depolarization (GO:0051899) | 3.07518132 |
91 | regulation of vesicle fusion (GO:0031338) | 3.05320214 |
92 | neuromuscular process controlling posture (GO:0050884) | 3.04895965 |
93 | photoreceptor cell development (GO:0042461) | 3.03425472 |
94 | regulation of synapse maturation (GO:0090128) | 3.03214114 |
95 | serotonin metabolic process (GO:0042428) | 3.02172145 |
96 | neuron recognition (GO:0008038) | 3.01511449 |
97 | startle response (GO:0001964) | 3.00967250 |
98 | neurofilament cytoskeleton organization (GO:0060052) | 3.00924863 |
99 | response to auditory stimulus (GO:0010996) | 3.00286871 |
100 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.00171019 |
101 | auditory behavior (GO:0031223) | 2.98832068 |
102 | mating behavior (GO:0007617) | 2.98183208 |
103 | behavioral response to ethanol (GO:0048149) | 2.97854984 |
104 | eye photoreceptor cell development (GO:0042462) | 2.96233344 |
105 | catecholamine transport (GO:0051937) | 2.96139273 |
106 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.95233002 |
107 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.94390529 |
108 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.94390529 |
109 | synaptic transmission (GO:0007268) | 2.94380958 |
110 | positive regulation of synaptic transmission (GO:0050806) | 2.93853624 |
111 | * regulation of neurotransmitter levels (GO:0001505) | 2.92923583 |
112 | primary amino compound metabolic process (GO:1901160) | 2.89500569 |
113 | mechanosensory behavior (GO:0007638) | 2.85612523 |
114 | adult walking behavior (GO:0007628) | 2.79807013 |
115 | protein localization to cilium (GO:0061512) | 2.78831221 |
116 | action potential (GO:0001508) | 2.78638407 |
117 | L-fucose catabolic process (GO:0042355) | 2.77539887 |
118 | fucose catabolic process (GO:0019317) | 2.77539887 |
119 | L-fucose metabolic process (GO:0042354) | 2.77539887 |
120 | glycerophospholipid catabolic process (GO:0046475) | 2.76606106 |
121 | dopamine biosynthetic process (GO:0042416) | 2.75953733 |
122 | detection of calcium ion (GO:0005513) | 2.69339388 |
123 | central nervous system myelination (GO:0022010) | 2.68684305 |
124 | axon ensheathment in central nervous system (GO:0032291) | 2.68684305 |
125 | nonmotile primary cilium assembly (GO:0035058) | 2.67769876 |
126 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.63476548 |
127 | axonal fasciculation (GO:0007413) | 2.62992184 |
128 | response to amphetamine (GO:0001975) | 2.62990440 |
129 | potassium ion transmembrane transport (GO:0071805) | 2.61823278 |
130 | cellular potassium ion transport (GO:0071804) | 2.61823278 |
131 | cellular ketone body metabolic process (GO:0046950) | 2.61079572 |
132 | negative regulation of dendrite development (GO:2000171) | 2.59557693 |
133 | atrial cardiac muscle cell action potential (GO:0086014) | 2.59425583 |
134 | synaptic transmission, cholinergic (GO:0007271) | 2.58300731 |
135 | reflex (GO:0060004) | 2.57394258 |
136 | adult behavior (GO:0030534) | 2.56129642 |
137 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.55689472 |
138 | regulation of neurotransmitter uptake (GO:0051580) | 2.52689350 |
139 | regulation of action potential (GO:0098900) | 2.50680083 |
140 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.49103527 |
141 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.49103527 |
142 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.49103527 |
143 | inositol phosphate catabolic process (GO:0071545) | 2.48932841 |
144 | positive regulation of meiosis (GO:0045836) | 2.47408586 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.79967232 |
2 | * GBX2_23144817_ChIP-Seq_PC3_Human | 4.16659156 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.82437269 |
4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.79381656 |
5 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.73099238 |
6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.66485008 |
7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.48440026 |
8 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.44274401 |
9 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.38937665 |
10 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.37121398 |
11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.34568482 |
12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.29448464 |
13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.29448464 |
14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.28071320 |
15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.26884763 |
16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.24617223 |
17 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.21931844 |
18 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.20742247 |
19 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.18276206 |
20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.07396297 |
21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.06863892 |
22 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.06233776 |
23 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.05772874 |
24 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.04762802 |
25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.04262714 |
26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.03080853 |
27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.00111455 |
28 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.97249868 |
29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.88947633 |
30 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.86772578 |
31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.85162906 |
32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.82692271 |
33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.80350016 |
34 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.71983287 |
35 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.71862237 |
36 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.70307217 |
37 | EWS_26573619_Chip-Seq_HEK293_Human | 1.69316732 |
38 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.68317276 |
39 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.63140698 |
40 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.62935565 |
41 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.55097969 |
42 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.52068022 |
43 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.50602893 |
44 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.50488044 |
45 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.48480896 |
46 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.48159772 |
47 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45209370 |
48 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42469756 |
49 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.41328044 |
50 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.39349384 |
51 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.39120440 |
52 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.38174271 |
53 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.36626009 |
54 | TCF4_23295773_ChIP-Seq_U87_Human | 1.35379183 |
55 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.34159757 |
56 | * AR_19668381_ChIP-Seq_PC3_Human | 1.33464150 |
57 | FUS_26573619_Chip-Seq_HEK293_Human | 1.32323014 |
58 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.32186513 |
59 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.32047237 |
60 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.31289959 |
61 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.30968874 |
62 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.28188963 |
63 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27585920 |
64 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.27430628 |
65 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25549018 |
66 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.25420038 |
67 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.25298002 |
68 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.24203251 |
69 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.24185414 |
70 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.23424910 |
71 | VDR_22108803_ChIP-Seq_LS180_Human | 1.22883573 |
72 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22728602 |
73 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.21682458 |
74 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.21538429 |
75 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.20568849 |
76 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.20568849 |
77 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.20448467 |
78 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.19110792 |
79 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.17820894 |
80 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.16254348 |
81 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15908373 |
82 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.14301327 |
83 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.14191220 |
84 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.13265976 |
85 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.12956759 |
86 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.12818572 |
87 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.12338622 |
88 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.12254366 |
89 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.11620221 |
90 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.11001270 |
91 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.09947666 |
92 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.09617616 |
93 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.09558917 |
94 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.09514958 |
95 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.09346457 |
96 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08400618 |
97 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08291564 |
98 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.08291564 |
99 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.07246826 |
100 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06185562 |
101 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.06085480 |
102 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.05391483 |
103 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.05385459 |
104 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05337231 |
105 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.05101221 |
106 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.04836173 |
107 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.04409947 |
108 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.04222018 |
109 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.04222018 |
110 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03455254 |
111 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.03398542 |
112 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.03095737 |
113 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.02829456 |
114 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.02539200 |
115 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.01388733 |
116 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01013337 |
117 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.00792778 |
118 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00714926 |
119 | TP53_16413492_ChIP-PET_HCT116_Human | 0.99972440 |
120 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99574879 |
121 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99503887 |
122 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.99055152 |
123 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.98755123 |
124 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.94983537 |
125 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94922183 |
126 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.93717926 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 4.93686803 |
2 | MP0003880_abnormal_central_pattern | 4.14613041 |
3 | MP0003635_abnormal_synaptic_transmissio | 3.64136467 |
4 | MP0004270_analgesia | 3.37320593 |
5 | MP0005551_abnormal_eye_electrophysiolog | 3.33230169 |
6 | MP0009046_muscle_twitch | 3.20935422 |
7 | MP0009745_abnormal_behavioral_response | 3.06184295 |
8 | MP0002063_abnormal_learning/memory/cond | 2.95848734 |
9 | MP0005423_abnormal_somatic_nervous | 2.94229687 |
10 | MP0002064_seizures | 2.91382030 |
11 | MP0002572_abnormal_emotion/affect_behav | 2.64042197 |
12 | MP0002272_abnormal_nervous_system | 2.63412890 |
13 | MP0001968_abnormal_touch/_nociception | 2.58860547 |
14 | MP0001486_abnormal_startle_reflex | 2.53487050 |
15 | MP0002734_abnormal_mechanical_nocicepti | 2.49655997 |
16 | MP0002822_catalepsy | 2.45360975 |
17 | MP0006072_abnormal_retinal_apoptosis | 2.32363119 |
18 | MP0001984_abnormal_olfaction | 2.13072393 |
19 | MP0005253_abnormal_eye_physiology | 2.09752997 |
20 | MP0002067_abnormal_sensory_capabilities | 2.04384086 |
21 | MP0002735_abnormal_chemical_nociception | 1.95039933 |
22 | MP0005646_abnormal_pituitary_gland | 1.92018849 |
23 | MP0001501_abnormal_sleep_pattern | 1.91452046 |
24 | MP0002909_abnormal_adrenal_gland | 1.85664810 |
25 | MP0001440_abnormal_grooming_behavior | 1.84734261 |
26 | MP0003787_abnormal_imprinting | 1.84095182 |
27 | MP0002736_abnormal_nociception_after | 1.83446300 |
28 | MP0008569_lethality_at_weaning | 1.83010075 |
29 | MP0009780_abnormal_chondrocyte_physiolo | 1.80713620 |
30 | MP0002184_abnormal_innervation | 1.78579453 |
31 | MP0001188_hyperpigmentation | 1.75999305 |
32 | MP0001970_abnormal_pain_threshold | 1.67805355 |
33 | MP0001502_abnormal_circadian_rhythm | 1.67114252 |
34 | MP0004924_abnormal_behavior | 1.64945489 |
35 | MP0005386_behavior/neurological_phenoty | 1.64945489 |
36 | MP0002733_abnormal_thermal_nociception | 1.64628928 |
37 | * MP0002557_abnormal_social/conspecific_i | 1.62814802 |
38 | MP0003879_abnormal_hair_cell | 1.62112365 |
39 | MP0000778_abnormal_nervous_system | 1.61322785 |
40 | MP0003195_calcinosis | 1.57512415 |
41 | MP0002882_abnormal_neuron_morphology | 1.56548882 |
42 | MP0002229_neurodegeneration | 1.56302180 |
43 | MP0004133_heterotaxia | 1.49277054 |
44 | MP0002638_abnormal_pupillary_reflex | 1.49079405 |
45 | MP0004811_abnormal_neuron_physiology | 1.48930448 |
46 | MP0004885_abnormal_endolymph | 1.47132727 |
47 | MP0002090_abnormal_vision | 1.45387232 |
48 | MP0002102_abnormal_ear_morphology | 1.45298807 |
49 | MP0001529_abnormal_vocalization | 1.44804929 |
50 | MP0005645_abnormal_hypothalamus_physiol | 1.42199983 |
51 | MP0010386_abnormal_urinary_bladder | 1.41432152 |
52 | MP0000955_abnormal_spinal_cord | 1.41019311 |
53 | MP0002066_abnormal_motor_capabilities/c | 1.30569814 |
54 | MP0004142_abnormal_muscle_tone | 1.28784852 |
55 | MP0003011_delayed_dark_adaptation | 1.27372436 |
56 | MP0003122_maternal_imprinting | 1.25199515 |
57 | MP0004145_abnormal_muscle_electrophysio | 1.23346779 |
58 | MP0000569_abnormal_digit_pigmentation | 1.22389435 |
59 | MP0003633_abnormal_nervous_system | 1.21923496 |
60 | MP0006276_abnormal_autonomic_nervous | 1.19327501 |
61 | MP0005195_abnormal_posterior_eye | 1.17844121 |
62 | MP0004858_abnormal_nervous_system | 1.17400686 |
63 | MP0004043_abnormal_pH_regulation | 1.16598948 |
64 | MP0002752_abnormal_somatic_nervous | 1.16255771 |
65 | MP0004742_abnormal_vestibular_system | 1.11972230 |
66 | MP0003329_amyloid_beta_deposits | 1.11118034 |
67 | MP0000631_abnormal_neuroendocrine_gland | 1.06974941 |
68 | MP0002152_abnormal_brain_morphology | 1.06634249 |
69 | MP0005394_taste/olfaction_phenotype | 1.06429696 |
70 | MP0005499_abnormal_olfactory_system | 1.06429696 |
71 | MP0004233_abnormal_muscle_weight | 1.02244318 |
72 | MP0003631_nervous_system_phenotype | 1.01159635 |
73 | MP0000013_abnormal_adipose_tissue | 1.00731284 |
74 | MP0003183_abnormal_peptide_metabolism | 0.99960025 |
75 | MP0005379_endocrine/exocrine_gland_phen | 0.99902476 |
76 | MP0006292_abnormal_olfactory_placode | 0.99387929 |
77 | MP0003283_abnormal_digestive_organ | 0.99280404 |
78 | MP0004147_increased_porphyrin_level | 0.96996584 |
79 | MP0002653_abnormal_ependyma_morphology | 0.96828447 |
80 | MP0003123_paternal_imprinting | 0.96246635 |
81 | MP0001986_abnormal_taste_sensitivity | 0.95239933 |
82 | MP0001963_abnormal_hearing_physiology | 0.93411507 |
83 | MP0001905_abnormal_dopamine_level | 0.92259655 |
84 | MP0000427_abnormal_hair_cycle | 0.91216586 |
85 | MP0002069_abnormal_eating/drinking_beha | 0.90160490 |
86 | MP0002938_white_spotting | 0.87703220 |
87 | MP0002928_abnormal_bile_duct | 0.87209856 |
88 | MP0003634_abnormal_glial_cell | 0.86322046 |
89 | MP0004215_abnormal_myocardial_fiber | 0.84780624 |
90 | MP0001324_abnormal_eye_pigmentation | 0.84653385 |
91 | MP0001485_abnormal_pinna_reflex | 0.84141018 |
92 | MP0003119_abnormal_digestive_system | 0.83701855 |
93 | MP0004085_abnormal_heartbeat | 0.83697820 |
94 | * MP0001944_abnormal_pancreas_morphology | 0.83380362 |
95 | MP0002234_abnormal_pharynx_morphology | 0.83317755 |
96 | MP0002163_abnormal_gland_morphology | 0.82323451 |
97 | MP0002160_abnormal_reproductive_system | 0.79572217 |
98 | MP0008872_abnormal_physiological_respon | 0.77438347 |
99 | MP0005391_vision/eye_phenotype | 0.76787998 |
100 | MP0005187_abnormal_penis_morphology | 0.75762399 |
101 | MP0000026_abnormal_inner_ear | 0.75644128 |
102 | MP0002751_abnormal_autonomic_nervous | 0.75008924 |
103 | MP0003632_abnormal_nervous_system | 0.74891580 |
104 | MP0003646_muscle_fatigue | 0.74297574 |
105 | MP0005174_abnormal_tail_pigmentation | 0.72271550 |
106 | MP0001177_atelectasis | 0.70381566 |
107 | MP0005389_reproductive_system_phenotype | 0.70356641 |
108 | MP0002837_dystrophic_cardiac_calcinosis | 0.69278977 |
109 | MP0003136_yellow_coat_color | 0.69246357 |
110 | * MP0002693_abnormal_pancreas_physiology | 0.68233073 |
111 | MP0008877_abnormal_DNA_methylation | 0.68099850 |
112 | MP0000678_abnormal_parathyroid_gland | 0.65105012 |
113 | MP0005535_abnormal_body_temperature | 0.63117576 |
114 | MP0002876_abnormal_thyroid_physiology | 0.62462734 |
115 | MP0003137_abnormal_impulse_conducting | 0.61587582 |
116 | MP0008874_decreased_physiological_sensi | 0.60576286 |
117 | MP0005409_darkened_coat_color | 0.60316113 |
118 | MP0003890_abnormal_embryonic-extraembry | 0.60185001 |
119 | MP0003121_genomic_imprinting | 0.58379342 |
120 | MP0001299_abnormal_eye_distance/ | 0.58369754 |
121 | MP0000751_myopathy | 0.56899125 |
122 | MP0003698_abnormal_male_reproductive | 0.55702419 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 6.42072764 |
2 | Congenital stationary night blindness (HP:0007642) | 6.15594014 |
3 | Epileptic encephalopathy (HP:0200134) | 5.20252221 |
4 | Focal seizures (HP:0007359) | 4.65275175 |
5 | Febrile seizures (HP:0002373) | 4.59750262 |
6 | Myokymia (HP:0002411) | 4.45528740 |
7 | Limb dystonia (HP:0002451) | 4.30412949 |
8 | Central scotoma (HP:0000603) | 4.26461974 |
9 | Abnormality of macular pigmentation (HP:0008002) | 4.14635689 |
10 | Progressive cerebellar ataxia (HP:0002073) | 4.12854157 |
11 | Visual hallucinations (HP:0002367) | 4.12843846 |
12 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.99891213 |
13 | Atonic seizures (HP:0010819) | 3.96251469 |
14 | Absence seizures (HP:0002121) | 3.79890580 |
15 | Gaze-evoked nystagmus (HP:0000640) | 3.69792723 |
16 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.53908187 |
17 | Dialeptic seizures (HP:0011146) | 3.50790327 |
18 | Molar tooth sign on MRI (HP:0002419) | 3.48797940 |
19 | Abnormality of midbrain morphology (HP:0002418) | 3.48797940 |
20 | Severe visual impairment (HP:0001141) | 3.47556319 |
21 | Action tremor (HP:0002345) | 3.45708624 |
22 | Nephronophthisis (HP:0000090) | 3.25370186 |
23 | Dysdiadochokinesis (HP:0002075) | 3.23581623 |
24 | Scotoma (HP:0000575) | 3.19666722 |
25 | Hyperventilation (HP:0002883) | 3.18734469 |
26 | Pancreatic fibrosis (HP:0100732) | 3.17859412 |
27 | Generalized tonic-clonic seizures (HP:0002069) | 3.16801997 |
28 | Pancreatic cysts (HP:0001737) | 3.16378991 |
29 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.15558584 |
30 | Broad-based gait (HP:0002136) | 3.15490996 |
31 | Truncal ataxia (HP:0002078) | 3.07870221 |
32 | Amblyopia (HP:0000646) | 2.96285900 |
33 | Dyschromatopsia (HP:0007641) | 2.96206398 |
34 | Decreased central vision (HP:0007663) | 2.91089572 |
35 | Hypothermia (HP:0002045) | 2.89442446 |
36 | True hermaphroditism (HP:0010459) | 2.88458732 |
37 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.83760907 |
38 | Impaired smooth pursuit (HP:0007772) | 2.81938333 |
39 | Dysmetric saccades (HP:0000641) | 2.80289085 |
40 | Type II lissencephaly (HP:0007260) | 2.77929678 |
41 | Genetic anticipation (HP:0003743) | 2.77200164 |
42 | Epileptiform EEG discharges (HP:0011182) | 2.76689000 |
43 | Scanning speech (HP:0002168) | 2.76593374 |
44 | Gait imbalance (HP:0002141) | 2.71647408 |
45 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.68935093 |
46 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.67768025 |
47 | Abnormality of the renal medulla (HP:0100957) | 2.67646425 |
48 | EEG with generalized epileptiform discharges (HP:0011198) | 2.65300266 |
49 | Depression (HP:0000716) | 2.64794170 |
50 | Ankle clonus (HP:0011448) | 2.61532351 |
51 | Poor eye contact (HP:0000817) | 2.61429949 |
52 | Attenuation of retinal blood vessels (HP:0007843) | 2.59358893 |
53 | Dysmetria (HP:0001310) | 2.57345184 |
54 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.56194730 |
55 | Polydipsia (HP:0001959) | 2.53077130 |
56 | Abnormal drinking behavior (HP:0030082) | 2.53077130 |
57 | Congenital primary aphakia (HP:0007707) | 2.49577755 |
58 | Abnormality of the labia minora (HP:0012880) | 2.46237729 |
59 | Polyphagia (HP:0002591) | 2.45558253 |
60 | Postural instability (HP:0002172) | 2.45454107 |
61 | Hemiparesis (HP:0001269) | 2.43659898 |
62 | Drooling (HP:0002307) | 2.43442871 |
63 | Excessive salivation (HP:0003781) | 2.43442871 |
64 | Impaired social interactions (HP:0000735) | 2.41925988 |
65 | Abnormal social behavior (HP:0012433) | 2.41925988 |
66 | Inability to walk (HP:0002540) | 2.36444895 |
67 | Hypsarrhythmia (HP:0002521) | 2.36046706 |
68 | Medial flaring of the eyebrow (HP:0010747) | 2.35854539 |
69 | Abnormality of the renal cortex (HP:0011035) | 2.32700428 |
70 | Type II diabetes mellitus (HP:0005978) | 2.31103833 |
71 | Choroideremia (HP:0001139) | 2.29203669 |
72 | Nephrogenic diabetes insipidus (HP:0009806) | 2.27220744 |
73 | Abnormal eating behavior (HP:0100738) | 2.27073707 |
74 | Absent speech (HP:0001344) | 2.26278840 |
75 | Spastic gait (HP:0002064) | 2.26202955 |
76 | Intestinal atresia (HP:0011100) | 2.25181394 |
77 | Cystic liver disease (HP:0006706) | 2.24690113 |
78 | Supranuclear gaze palsy (HP:0000605) | 2.23840772 |
79 | Anxiety (HP:0000739) | 2.23643642 |
80 | Chronic hepatic failure (HP:0100626) | 2.20702958 |
81 | Lissencephaly (HP:0001339) | 2.17464177 |
82 | Pheochromocytoma (HP:0002666) | 2.08884917 |
83 | Intention tremor (HP:0002080) | 2.08837800 |
84 | Retinitis pigmentosa (HP:0000510) | 2.07094473 |
85 | Photophobia (HP:0000613) | 2.06309157 |
86 | Impaired vibratory sensation (HP:0002495) | 2.02028961 |
87 | Bradykinesia (HP:0002067) | 2.01770947 |
88 | Progressive inability to walk (HP:0002505) | 2.01465938 |
89 | Abnormality of the lower motor neuron (HP:0002366) | 2.00614727 |
90 | Oligodactyly (hands) (HP:0001180) | 1.99886332 |
91 | Decreased circulating renin level (HP:0003351) | 1.97225374 |
92 | Pachygyria (HP:0001302) | 1.97081780 |
93 | Specific learning disability (HP:0001328) | 1.95887624 |
94 | Pendular nystagmus (HP:0012043) | 1.93879805 |
95 | Poor coordination (HP:0002370) | 1.93448606 |
96 | Prolonged QT interval (HP:0001657) | 1.92955706 |
97 | Large for gestational age (HP:0001520) | 1.92641744 |
98 | Vaginal atresia (HP:0000148) | 1.92549671 |
99 | Genital tract atresia (HP:0001827) | 1.92470206 |
100 | Chorioretinal atrophy (HP:0000533) | 1.91929025 |
101 | Polyuria (HP:0000103) | 1.91779049 |
102 | Tubular atrophy (HP:0000092) | 1.91702761 |
103 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.90636917 |
104 | Abnormality of the corticospinal tract (HP:0002492) | 1.90446040 |
105 | Agitation (HP:0000713) | 1.87964461 |
106 | Cerebellar dysplasia (HP:0007033) | 1.87003133 |
107 | Protruding tongue (HP:0010808) | 1.85495889 |
108 | Ketoacidosis (HP:0001993) | 1.84413092 |
109 | Retinal atrophy (HP:0001105) | 1.84194139 |
110 | Stereotypic behavior (HP:0000733) | 1.83465713 |
111 | Blue irides (HP:0000635) | 1.82941122 |
112 | Methylmalonic acidemia (HP:0002912) | 1.82910701 |
113 | Abolished electroretinogram (ERG) (HP:0000550) | 1.82787850 |
114 | Hemiplegia (HP:0002301) | 1.82431846 |
115 | Hypomagnesemia (HP:0002917) | 1.81612461 |
116 | Pigmentary retinal degeneration (HP:0001146) | 1.81262808 |
117 | Optic nerve hypoplasia (HP:0000609) | 1.81220285 |
118 | Sclerocornea (HP:0000647) | 1.81052922 |
119 | Status epilepticus (HP:0002133) | 1.80441246 |
120 | Neuroendocrine neoplasm (HP:0100634) | 1.77874988 |
121 | Gait ataxia (HP:0002066) | 1.76948478 |
122 | Abnormal EKG (HP:0003115) | 1.76619020 |
123 | Thyroid-stimulating hormone excess (HP:0002925) | 1.76076976 |
124 | Progressive macrocephaly (HP:0004481) | 1.75719950 |
125 | Lower limb muscle weakness (HP:0007340) | 1.75508315 |
126 | Retinal dysplasia (HP:0007973) | 1.75095799 |
127 | Horizontal nystagmus (HP:0000666) | 1.74481118 |
128 | Urinary urgency (HP:0000012) | 1.74428252 |
129 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.74299361 |
130 | Abnormality of saccadic eye movements (HP:0000570) | 1.73024051 |
131 | Absent/shortened dynein arms (HP:0200106) | 1.72867830 |
132 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.72867830 |
133 | Bile duct proliferation (HP:0001408) | 1.71895139 |
134 | Abnormal biliary tract physiology (HP:0012439) | 1.71895139 |
135 | Tachypnea (HP:0002789) | 1.71751895 |
136 | Keratoconus (HP:0000563) | 1.71631978 |
137 | Increased corneal curvature (HP:0100692) | 1.71631978 |
138 | Double outlet right ventricle (HP:0001719) | 1.71089764 |
139 | Congenital malformation of the right heart (HP:0011723) | 1.71089764 |
140 | Diplopia (HP:0000651) | 1.70920047 |
141 | Abnormality of binocular vision (HP:0011514) | 1.70920047 |
142 | Limb ataxia (HP:0002070) | 1.70699838 |
143 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.70455273 |
144 | Muscular hypotonia of the trunk (HP:0008936) | 1.68269091 |
145 | Acute necrotizing encephalopathy (HP:0006965) | 1.67755766 |
146 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.66161787 |
147 | Spastic tetraplegia (HP:0002510) | 1.64749171 |
148 | Dyskinesia (HP:0100660) | 1.64177862 |
149 | Mitochondrial inheritance (HP:0001427) | 1.64094405 |
150 | Renal cortical cysts (HP:0000803) | 1.62794269 |
151 | Congenital sensorineural hearing impairment (HP:0008527) | 1.61905069 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 4.18172620 |
2 | EPHA4 | 3.52351773 |
3 | CASK | 3.36058997 |
4 | MAP3K4 | 3.17886173 |
5 | MARK1 | 2.81666061 |
6 | MAP3K9 | 2.79822911 |
7 | MAP2K7 | 2.60931015 |
8 | DAPK2 | 2.46496675 |
9 | MINK1 | 2.31918808 |
10 | PAK6 | 2.15402396 |
11 | NTRK2 | 2.14017529 |
12 | BMPR1B | 2.00517166 |
13 | TNIK | 1.97525658 |
14 | ADRBK2 | 1.92586309 |
15 | MAP4K2 | 1.92502027 |
16 | PRPF4B | 1.90935086 |
17 | PRKD3 | 1.83338093 |
18 | INSRR | 1.66619043 |
19 | CAMKK1 | 1.64539263 |
20 | CAMKK2 | 1.64426422 |
21 | MAP2K4 | 1.59445180 |
22 | ZAK | 1.55485898 |
23 | NTRK1 | 1.54078778 |
24 | SIK2 | 1.51301632 |
25 | AKT3 | 1.50892850 |
26 | ACVR1B | 1.50721350 |
27 | KSR1 | 1.50209085 |
28 | DAPK1 | 1.45436895 |
29 | CDK19 | 1.45103393 |
30 | CAMK1D | 1.44099305 |
31 | MAPK13 | 1.41877392 |
32 | CDK5 | 1.41575520 |
33 | STK38 | 1.40791448 |
34 | PNCK | 1.40737798 |
35 | SGK494 | 1.39379545 |
36 | SGK223 | 1.39379545 |
37 | FGFR2 | 1.38404268 |
38 | SGK2 | 1.34079398 |
39 | DYRK2 | 1.33447760 |
40 | PLK2 | 1.25916998 |
41 | PRKCG | 1.22727045 |
42 | KSR2 | 1.22076105 |
43 | MKNK2 | 1.15516662 |
44 | CSNK1G1 | 1.14370115 |
45 | STK39 | 1.13281566 |
46 | TRIM28 | 1.12574169 |
47 | CSNK1G3 | 1.11204039 |
48 | WNK3 | 1.08173609 |
49 | UHMK1 | 1.07519325 |
50 | MAP3K12 | 1.06954893 |
51 | OXSR1 | 1.05301241 |
52 | TLK1 | 1.04804234 |
53 | FES | 1.04171545 |
54 | RIPK4 | 1.03814279 |
55 | CAMK2A | 1.02393806 |
56 | GRK5 | 1.01907736 |
57 | SGK3 | 0.99339592 |
58 | MAP3K2 | 0.96886810 |
59 | CCNB1 | 0.96438724 |
60 | WNK1 | 0.96286450 |
61 | PINK1 | 0.93446794 |
62 | DYRK1A | 0.92842236 |
63 | NUAK1 | 0.90656363 |
64 | GRK1 | 0.90120129 |
65 | CAMK1G | 0.85532635 |
66 | SGK1 | 0.84135211 |
67 | STK16 | 0.83507192 |
68 | CAMK1 | 0.83169138 |
69 | CDK18 | 0.83015225 |
70 | CAMK2B | 0.82841713 |
71 | BCR | 0.80710502 |
72 | CAMK2D | 0.80324719 |
73 | CDK15 | 0.78265312 |
74 | MAPKAPK5 | 0.77752538 |
75 | TYRO3 | 0.77616675 |
76 | SIK3 | 0.76961115 |
77 | STK11 | 0.76410851 |
78 | CDK3 | 0.76250010 |
79 | CDK14 | 0.76050760 |
80 | STK38L | 0.76019985 |
81 | PRKCH | 0.74425803 |
82 | PHKG2 | 0.74168916 |
83 | PHKG1 | 0.74168916 |
84 | CDC42BPA | 0.73892151 |
85 | PIK3CA | 0.72784613 |
86 | NEK6 | 0.68468114 |
87 | CDK11A | 0.67444452 |
88 | ARAF | 0.66791999 |
89 | CSNK1A1L | 0.66423545 |
90 | MARK2 | 0.66082397 |
91 | PAK3 | 0.62866675 |
92 | BMPR2 | 0.61250106 |
93 | PRKCE | 0.59090322 |
94 | FRK | 0.59026261 |
95 | CSNK1G2 | 0.57922993 |
96 | PKN1 | 0.56931068 |
97 | * RPS6KA3 | 0.56415620 |
98 | BRAF | 0.55406421 |
99 | RET | 0.55329374 |
100 | CSNK1E | 0.54295039 |
101 | NEK1 | 0.54095524 |
102 | CAMK4 | 0.53275731 |
103 | TNK2 | 0.52808872 |
104 | PRKCZ | 0.52489348 |
105 | MAPK10 | 0.52369265 |
106 | CSNK1A1 | 0.52214324 |
107 | PTK2B | 0.50366705 |
108 | CSNK1D | 0.49600845 |
109 | TIE1 | 0.48399549 |
110 | PRKCB | 0.48062424 |
111 | FER | 0.47214982 |
112 | PRKCI | 0.46515529 |
113 | PRKAA1 | 0.46440740 |
114 | CAMK2G | 0.45360528 |
115 | ERBB2 | 0.44971409 |
116 | PDK1 | 0.44744620 |
117 | ADRBK1 | 0.43955704 |
118 | PRKACA | 0.42587401 |
119 | ERBB3 | 0.42085318 |
120 | PDPK1 | 0.40793103 |
121 | WNK4 | 0.40471966 |
122 | MAP2K6 | 0.40285026 |
123 | PLK4 | 0.39976229 |
124 | PRKCA | 0.39535424 |
125 | HIPK2 | 0.39430051 |
126 | BRD4 | 0.39248251 |
127 | * PRKG1 | 0.38643111 |
128 | MAP3K6 | 0.37939528 |
129 | ALK | 0.37909074 |
130 | NME1 | 0.37598794 |
131 | MAP3K13 | 0.37275835 |
132 | GSK3B | 0.36994799 |
133 | RAF1 | 0.36910631 |
134 | TAOK3 | 0.35645432 |
135 | PLK3 | 0.35592199 |
136 | PRKACB | 0.33789814 |
137 | LIMK1 | 0.30673888 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Phototransduction_Homo sapiens_hsa04744 | 4.05005120 |
2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.88797759 |
3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.54044880 |
4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.97687496 |
5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.84897146 |
6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.76866156 |
7 | Morphine addiction_Homo sapiens_hsa05032 | 2.74129795 |
8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.69476396 |
9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.62618760 |
10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.34517276 |
11 | * Insulin secretion_Homo sapiens_hsa04911 | 2.32898313 |
12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.31067695 |
13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.15785303 |
14 | Salivary secretion_Homo sapiens_hsa04970 | 2.04815057 |
15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.94689925 |
16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.93265064 |
17 | Taste transduction_Homo sapiens_hsa04742 | 1.92576280 |
18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.90737407 |
19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.90066466 |
20 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.90007223 |
21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.81139382 |
22 | Renin secretion_Homo sapiens_hsa04924 | 1.73123260 |
23 | Protein export_Homo sapiens_hsa03060 | 1.72592577 |
24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.72034226 |
25 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.64085356 |
26 | Long-term depression_Homo sapiens_hsa04730 | 1.63398780 |
27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.61841122 |
28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.58996080 |
29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.52488545 |
30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.50020781 |
31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.49889229 |
32 | Parkinsons disease_Homo sapiens_hsa05012 | 1.47354482 |
33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.44401858 |
34 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.41330604 |
35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.39188000 |
36 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.33746200 |
37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.29208435 |
38 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.24241158 |
39 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.22799307 |
40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.22023996 |
41 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.21860792 |
42 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.20128603 |
43 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.18578627 |
44 | Gap junction_Homo sapiens_hsa04540 | 1.17863818 |
45 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.17649563 |
46 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.16715225 |
47 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.15418939 |
48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.14467118 |
49 | Circadian rhythm_Homo sapiens_hsa04710 | 1.14178518 |
50 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.13774081 |
51 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.10964011 |
52 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.10765016 |
53 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.09941573 |
54 | Alzheimers disease_Homo sapiens_hsa05010 | 1.09473372 |
55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08051288 |
56 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.07497918 |
57 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.03510514 |
58 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93863828 |
59 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.93699687 |
60 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.93075623 |
61 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.91574257 |
62 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.88595811 |
63 | Huntingtons disease_Homo sapiens_hsa05016 | 0.86604685 |
64 | Axon guidance_Homo sapiens_hsa04360 | 0.86372172 |
65 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.85480257 |
66 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.83006338 |
67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.81388512 |
68 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80133319 |
69 | ABC transporters_Homo sapiens_hsa02010 | 0.79200245 |
70 | Melanogenesis_Homo sapiens_hsa04916 | 0.78490467 |
71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77905259 |
72 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.76240570 |
73 | Glioma_Homo sapiens_hsa05214 | 0.75211052 |
74 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73564337 |
75 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.73254146 |
76 | RNA polymerase_Homo sapiens_hsa03020 | 0.71674885 |
77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.70836930 |
78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69980698 |
79 | Basal transcription factors_Homo sapiens_hsa03022 | 0.69465861 |
80 | Alcoholism_Homo sapiens_hsa05034 | 0.68503889 |
81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67809386 |
82 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.67620928 |
83 | Peroxisome_Homo sapiens_hsa04146 | 0.66706543 |
84 | Homologous recombination_Homo sapiens_hsa03440 | 0.66236048 |
85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65433067 |
86 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.64162495 |
87 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.64020099 |
88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61471701 |
89 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.60735924 |
90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58527120 |
91 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.56607969 |
92 | RNA degradation_Homo sapiens_hsa03018 | 0.55810673 |
93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55379603 |
94 | Mineral absorption_Homo sapiens_hsa04978 | 0.55193141 |
95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.54522557 |
96 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52992459 |
97 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.51918075 |
98 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.51816664 |
99 | Histidine metabolism_Homo sapiens_hsa00340 | 0.51499031 |
100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51222014 |
101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50762848 |
102 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.49774455 |
103 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.48380773 |
104 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47858003 |
105 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46913781 |
106 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.46631235 |
107 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45660855 |
108 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44688009 |
109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.43255948 |
110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41153349 |
111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40710184 |
112 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.40201639 |
113 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.40108470 |
114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39697849 |
115 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38151192 |
116 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.37898641 |
117 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36386970 |
118 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.34870887 |
119 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34399195 |
120 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.34177206 |
121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33869962 |
122 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33792750 |
123 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.32898908 |
124 | Purine metabolism_Homo sapiens_hsa00230 | 0.32629292 |
125 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.32176935 |
126 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31423895 |
127 | Endocytosis_Homo sapiens_hsa04144 | 0.31216899 |
128 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.30746270 |
129 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30465537 |
130 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30039475 |
131 | Bile secretion_Homo sapiens_hsa04976 | 0.29708222 |
132 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.29473883 |
133 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.27112937 |
134 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.25703259 |
135 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.25583536 |
136 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.25332452 |
137 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.24446564 |
138 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.23540667 |
139 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.19619290 |
140 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.19088664 |
141 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.18879646 |
142 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.18541819 |
143 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.18118726 |